Asia-Pacific is rapidly gaining importance as a major pillar in global life science innovation

SEOUL, Korea, Nov 2 (Bernama) -- Boehringer Ingelheim today highlighted Asia-Pacific’s increasing importance in global life science innovation. Speaking at the Asia-Pacific Conference of German Business (APK) 2026 in Seoul, Shashank Deshpande, Boehringer Ingelheim Chairman of the Board of Managing Directors, said that “Asia-Pacific is rapidly gaining importance as a major pillar in global life science innovation”, driving patient access to new medicines and improving animal health and food chain safety and security.

“Predictable and science-friendly policy frameworks that attract investment are essential to improve access to new human and animal health products,” Deshpande said. “As international competition for talent, research and development capabilities and investments is increasing globally, Asia-Pacific is rapidly gaining importance in life science innovation.” He went on to explain: “We draw on Europe’s scientific depth, the broad US innovation environment and Asia-Pacific’s speed, scale and growing R&D capabilities to drive our global innovation engine. Our ability to integrate technologies and scientific expertise from around the world puts Boehringer in a strong position to deliver breakthrough innovation for the patients and animals we care for.”